abstract |
The present invention concerns nanoparticles with a core comprising a phenazine derivative and a shell comprising at least one layer of a nucleolipid, compositions comprising them and their pharmaceutical uses, especially in the prevention and/or treatment of diseases in which the interaction between the proteins Hsp27 and eIF4E is involved. |